Biotechnology Laws and Regulations in USA
Lawyers with expertise in Biotechnology and Patent Laws assist global clients through the Biotech laws and Regulations
Lawyers with expertise in Biotechnology and Patent Laws assist global clients through the Biotech laws and Regulations
A policy containing various ministries of the central administration regulates the existing biotechnology laws in India.
It is predicted that the Biotechnology Laws in Europe will provide for a better efficiency in regulatory structure.
Biotech is tremendously broad and multidisciplinary, with applications fluctuating from genetic engineering to biomedical research based innovations.
BioSpectrum Asia – Debate over compulsory licensing of Bayer’s Nexavar Originally published here. Full Article: India allows compulsory licensing of Bayer’s Nexavar In March 2012, the Indian Patent office granted first compulsory license to NATCO…
Monsanto filed patent application No.2407/DEL/NP/2006 on 01/05/2006. The patent office examined the claimed subject matter and raised objections on various grounds specified under Section 3 of the patents act. Monsanto responded to objections and presented…
Patent Opposition in India includes pre-grant and post-grant opposition proceedings.
By 2020, according to Frost & Sullivan, healthcare expenditure in the APAC will increase 151 percent over 2010 figure, to $2927 billion at a compound annual growth rate of 9.2 percent. Factors such as increasing…
Global Legal Post Publication Before US visit, PM Modi announced to resolve one the most crucial issues daunting the Indian Patent Office, i.e. clearing the huge backlog. Originally published here. Full Article: 1,000 backlog beaters for…
Swissinfo is Swiss Government’s International Publication Service managed by Swiss Broadcasting Corporation (SBC). Originally published here. Views on Delhi High Court’s ruling in Novartis patent dispute: “The ruling is totally in line with existing laws,…